Gartner PAM Market Guide 2017
senhasegura consolidates its position in the privileged access market.

Gartner is one of the most respected Information Technology research and consulting organizations, and assists professionals in businesses of all sizes to make decisions every day.
The Gartner Market Guide for Privileged Access Management 2017 provides an overview of the Privileged Access Management market with key trends and analysis of the 24 largest vendors for these solutions. This guide is a reference in the I.T. market and is used by information security professionals to evaluate solutions that help their companies protect themselves from privileged access threats.
Request a demo with an expert and understand what your business needs
Among the 24 vendors of PASM (Privileged Access and Session Management) solutions listed by Gartner, senhasegura consolidates among those with all the key features required for the high privilege credential security market. This allows security professionals to control, monitor, and properly manage accesses from privileged users to critical systems.
In 2017, senhasegura had already been listed by Gartner as Cool Vendor and by KuppingerCole on the Leadership Compass. In addition to these facts, we have figured in the Market Guide for Privileged Access Management in 2016.
The listing of MT4 Tecnologia in the documents published by Gartner for the second year in a row strenghts the position of senhasegura among the most important PAM solutions on the market and reinforces our commitment to produce the best solution for privileged information protection.
Required Disclaimer:
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.